Newsroom
301 articles
FeaturedFDA Approves New Treatment for Uncomplicated Urinary Tract Infections Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated…
ImportantETF recommends updating COVID-19 vaccines to target new JN.1 variant Updated vaccines will help maintain protection against disease as virus continues to evolve, MA’s Emergency Task Force (ETF)…
FeaturedFDA Approves New Antimicrobial Drug for Cattle and Swine Today, the U.S. Food and Drug Administration approved Pradalex (pradofloxacin injection) solution for certain respiratory diseases in cattle and…
ImportantPRAC committee latest meeting doesn’t support a causal association between the Glucagon-Like Peptide-1 receptor agonists (GLP-1) and suicidal and self-injurious thoughts and actions The PRAC has concluded that…
ImportantTGA Updated warnings of faricimab (Vabysmo) retinal vasculitis risk Faricimab is indicated for: Neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) Faricimab 6 mg/0.05 mL…
FeaturedNew combined antibiotic approved to treat adult patients with severe infections of the urinary tract and hospital-acquired pneumonia The Medicines and Healthcare products Regulatory Agency (MHRA) has today…
ImportantFDA Warns Consumers about Potential for Dangerous Health Effects that can result from Certain Topical Pain Relief Products The U.S. Food and Drug Administration is warning consumers not…
ImportantToday, the U.S. Food and Drug Administration approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), to…
FeaturedEMA’s safety committee (PRAC) concluded that there was insufficient evidence to establish a causal association between the COVID-19 vaccines Comirnaty and Spikevax and cases of postmenopausal bleeding. Postmenopausal…
FeaturedThe European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have launched new lists that show where scientists can find real-world data and studies. These lists…
FeaturedMHRA approved the Rubidium (Rb82) Generator (RUBY-FILL) as a diagnostic tool for imaging of the heart to aid in the diagnosis of suspected or known coronary heart disease…
ImportantPseudoephedrine is licensed for the symptomatic relief of nasal and sinus congestion in colds, flu, and allergies. It has been used in the UK for decades by millions…
FeaturedIn a groundbreaking stride towards revolutionizing the field of stem cell therapy, the Head of the Medicines and Healthcare products Regulatory Agency’s UK Stem Cell Bank (UKSCB) has…
FeaturedIn a significant development, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended against renewing the marketing authorization for Translarna (ataluren), a…
FeaturedToday, the U.S. Food and Drug Administration announced the creation of a new Digital Health Advisory Committee to help the agency explore the complex, scientific and technical issues…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP